Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 Black Phoenix Black Phoenix +336.77%
#4 aPriori aPriori +120.78%
#5 Bedrock Bedrock +76.11%
#6 Cysic Cysic +49.09%
#7 Prom Prom +41.94%
#8 Playnance Playnance +35.13%
#9 COTI COTI +25.33%
#10 Nillion Nillion +24.72%
Coin of the day
Wrapped One Wrapped One
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Virpax Pharmaceuticals, Inc. Virpax Pharmaceuticals, Inc.

Virpax Pharmaceuticals, Inc.

VRPX
Rang in aandelen #42776
Virpax Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical... Virpax Pharmaceuticals, Inc. operates as a preclinical-stage pharmaceutical enterprise, dedicated to pioneering diverse drug-delivery systems and novel drug-releasing technologies. Its core focus lies in developing advanced, non-opioid and non-addictive solutions for pain management, alongside therapies targeting central nervous system disorders. The company's current investigational pipeline features several preclinical product candidates. These include Epoladerm, a topical nonsteroidal anti-inflammatory drug (NSAID) designed to address chronic osteoarthritis of the knee, and Probudur, an injectable liposomal gel formulated as a local anesthetic for managing post-operative pain. Also in development are Envelta and PES200, both nanotechnology-based intranasal spray drug candidates engineered to deliver metabolically labile peptide drugs directly to the brain. Further candidates comprise AnQlar, an antiviral barrier solution intended to prevent or lessen the severity of human viral infections such as influenza and SARS-CoV-2, and VRP324, an experimental nasal formulation aimed at enhancing the transport of cannabidiol into the brain. Virpax Pharmaceuticals, Inc. was established in 2016 and is based in Berwyn, Pennsylvania.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$124.00
Verandering (1 dag)
0.00%
Verandering (1 jaar)
-99.09%
Land
US
Handel Virpax Pharmaceuticals, Inc. (VRPX)

Categorie

Healthcare
Koersgeschiedenis voor Virpax Pharmaceuticals, Inc. (VRPX)
Hoogste slotkoers: $0.00 op 2026-08-01

Laagste slotkoers: $1.50K op 2021-02-01
Koersgeschiedenis van Virpax Pharmaceuticals, Inc. van 2021 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -45.38%
2025 -99.76%
2024 -90.10%
2023 -52.53%
2022 -79.82%
2021 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 36.13%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 37.02%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.38 8.73%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $263.09 20.45%
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -5.56%
KR